The Time is Ripe for a Randomized Controlled Trial of Oral Vancomycin in Primary Sclerosing Cholangitis

被引：0
|
作者：
Halma, Jennifer Christine [1 ]
Cristoferi, Laura [2 ]
Carbone, Marco [2 ]
机构：
[1] Stanford Univ, Lucile Packard Childrens Hosp, Sch Med, Div Gastroenterol Hepatol & Nutr,Dept Pediat, Stanford, CA 94305 USA
[2] Univ Milano Bicocca, Ctr Autoimmune Liver Dis, Dept Med & Surg, Div Gastroenterol, Monza, Italy
来源：
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY | 2023年 / 21卷 / 10期
关键词：
D O I：
10.1016/j.cgh.2022.11.017
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：2699 / 2700
页数：2
相关论文
共 50 条
  • [21] Commentary: vancomycin or metronidazole in patients with primary sclerosing cholangitis?
    Paterson, J. C. M.
    Dillon, J. F.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (09) : 915 - 915
  • [22] Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis - a pilot study
    Tabibian, J. H.
    Weeding, E.
    Jorgensen, R. A.
    Petz, J. L.
    Keach, J. C.
    Talwalkar, J. A.
    Lindor, K. D.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (06) : 604 - 612
  • [23] Editorial: Is it time to include oral vancomycin in therapeutic guidelines for primary sclerosing cholangitis-associated inflammatory bowel disease?
    Shah, Ayesha
    Holtmann, Gerald
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (10) : 1290 - 1291
  • [24] Clinical Outcomes of Oral Vancomycin Therapy for Children with Primary Sclerosing Cholangitis in the Pediatric PSC Consortium
    Deneau, Mark
    Abdou, Reham
    Amin, Mansi
    Amir, Achiya Z.
    Auth, Marcus
    Broderick, Annemarie
    Chan, Albert
    DiGuglielmo, Matthew
    El-Matary, Wael
    El-Youssef, Mounif
    Ferrari, Federica
    Furuya, Katryn
    Gottrand, Frederic
    Gupta, Nitika Arora
    Homan, Matjaz
    Jensen, M. Kyle
    Kamath, Binita M.
    Kim, Kyung Mo
    Kolho, Kaija-Leena
    Konidari, Anastasia
    Koot, Bart
    Iorio, Raffaele
    Lin, Henry C.
    Mack, Cara Lynn
    Martinez, Mercedes
    Mohan, Parvathi
    Palle, Sirish Kumar
    Papadopoulou, Alexandra
    Perito, Emily J. Rothbaum
    Ricciuto, Amanda
    Saubermann, Lawrence
    Sathya, Pushpa
    Shah, Uzma
    Shteyer, Eyal
    Smolka, Vratislav
    Tanaka, Atsushi
    Valentino, Pamela L.
    Varier, Raghu
    Venkat, Veena L.
    Vitola, Bernadette
    Vos, Miriam B.
    Woynarowski, Marek
    Yap, Jason Y. K.
    Miloh, Tamir
    HEPATOLOGY, 2018, 68 : 114A - 115A
  • [25] The Effectiveness of Oral Vancomycin on Inflammatory Bowel Disease in Patients With Primary Sclerosing Cholangitis: A Systematic Review
    Arbabzada, Naik
    Dennett, Liz
    Meng, Guanmin
    Peerani, Farhad
    INFLAMMATORY BOWEL DISEASES, 2024,
  • [26] Long-term treatment of primary sclerosing cholangitis in children with oral vancomycin: An immunomodulating antibiotic
    Davies, Yinka K.
    Cox, Kathleen M.
    Abdullah, Bisher A.
    Safta, Anca
    Terry, Annie B.
    Cox, Kenneth L.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2008, 47 (01): : 61 - 67
  • [27] Successful Treatment of Primary Sclerosing Cholangitis With Oral Vancomycin for Over 7 Years: A Case Report
    Mahajan, Ashley
    Sharpio, Arielle
    Mahajan, Lori
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S779 - S779
  • [28] How frequent are vancomycin-resistant enterococci in patients with primary sclerosing cholangitis and ulcerative colitis treated with oral vancomycin?
    Shah, Ayesha
    Pakneeshan, Sahar
    Jones, Michael P.
    Koloski, Natasha
    Callaghan, Gavin
    Morrison, Mark
    Holtmann, Gerald
    INDIAN JOURNAL OF GASTROENTEROLOGY, 2022, 41 (05) : 519 - 524
  • [29] How frequent are vancomycin-resistant enterococci in patients with primary sclerosing cholangitis and ulcerative colitis treated with oral vancomycin?
    Ayesha Shah
    Sahar Pakneeshan
    Michael P Jones
    Natasha Koloski
    Gavin Callaghan
    Mark Morrison
    Gerald Holtmann
    Indian Journal of Gastroenterology, 2022, 41 : 519 - 524
  • [30] Editorial: vancomycin - a promising option for the treatment of primary sclerosing cholangitis?
    Chapman, R. W.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (09) : 1321 - 1322
12345